⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IBIO News
iBio, Inc. Common Stock
iBio Unveils New Non-Human Primate Data on IBIO-610, an Activin E Antibody with Strong Therapeutic Potential for Fat-Selective Weight-Loss and Weight Maintenance
globenewswire.com
IBIO
Epilepsy Market Set to Grow During the Forecast Period (2026-2036) as Novel Antiseizure Therapies Gain Momentum | DelveInsight
prnewswire.com
XENE
BHVN
STOK
NBIX
NVS
UCB
VRTX
GSK
SAN
MDT
IBIO
BMB
OVID
PTC